We recently published a list of Jim Cramer Discusses These 10 Stocks & Says US Faces Unfairly High Tariffs Abroad. In this article, we are going to take a look at where Vertex Pharmaceuticals ...

Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF). It markets TRIKAFTA/KAFTRIO for people with CF ...

Fortescue's Andrew Forrest discusses his outlook for the commodities sector in an interview with Bloomberg Television on the sidelines of the Boao Forum in China. The billionaire founder says the ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Feb. 25, 2025 — Researchers have developed a battery that can convert nuclear energy into electricity via light emission, a study ... Scientists Crack the Code to Longer-Lasting Perovskite Solar ...

After hours: March 26 at 7:34:24 PM EDT Loading Chart for VRTX ...

Mar. 25, 2025 — Exposure to antibiotics during a key developmental window in infancy can stunt growth of insulin-producing cells in the pancreas and may boost risk of diabetes later in life, new ...